substrates of p-glycoprotein are susceptible to changes in pharmacokinetics due to drug interactions with p-gp inhibitors or inducers. some of these substrates include colchicine, ciclosporin, dabigatran, digoxin, diltiazem, fexofenadine, indinavir, morphine, and sirolimus.